Global Molecular Diagnostics Cancer Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-52145 | Geographical Scope: Global | Publisher: HNY Research
The global Molecular Diagnostics Cancer market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Roche Invitae Abbott Laboratories Danaher MDxHealth Siemens Thermo Fisher Scientific AstraZeneca ICON Plc PlexBio Foundation Medicine CytoTrack Guardant Health Luminex 10X Genomics Merck Biocartis GenomOncology Biodesix Bio-Techne By Types: Pharmacogenomic Diagnosis Liquid Biopsy Other By Applications: Respiratory Cancer Cancer of Digestive System Cancer of Urinary System Cancer of Circulatory System Motor System Cancer Reproductive System Cancer Other Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue 1.5 Market Analysis by Type 1.5.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Pharmacogenomic Diagnosis 1.5.3 Liquid Biopsy 1.5.4 Other 1.6 Market by Application 1.6.1 Global Molecular Diagnostics Cancer Market Share by Application: 2022-2027 1.6.2 Respiratory Cancer 1.6.3 Cancer of Digestive System 1.6.4 Cancer of Urinary System 1.6.5 Cancer of Circulatory System 1.6.6 Motor System Cancer 1.6.7 Reproductive System Cancer 1.6.8 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Molecular Diagnostics Cancer Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Molecular Diagnostics Cancer Market Players Profiles 3.1 Roche 3.1.1 Roche Company Profile 3.1.2 Roche Molecular Diagnostics Cancer Product Specification 3.1.3 Roche Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Invitae 3.2.1 Invitae Company Profile 3.2.2 Invitae Molecular Diagnostics Cancer Product Specification 3.2.3 Invitae Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Abbott Laboratories 3.3.1 Abbott Laboratories Company Profile 3.3.2 Abbott Laboratories Molecular Diagnostics Cancer Product Specification 3.3.3 Abbott Laboratories Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Danaher 3.4.1 Danaher Company Profile 3.4.2 Danaher Molecular Diagnostics Cancer Product Specification 3.4.3 Danaher Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 MDxHealth 3.5.1 MDxHealth Company Profile 3.5.2 MDxHealth Molecular Diagnostics Cancer Product Specification 3.5.3 MDxHealth Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Siemens 3.6.1 Siemens Company Profile 3.6.2 Siemens Molecular Diagnostics Cancer Product Specification 3.6.3 Siemens Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Thermo Fisher Scientific 3.7.1 Thermo Fisher Scientific Company Profile 3.7.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Specification 3.7.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 AstraZeneca 3.8.1 AstraZeneca Company Profile 3.8.2 AstraZeneca Molecular Diagnostics Cancer Product Specification 3.8.3 AstraZeneca Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 ICON Plc 3.9.1 ICON Plc Company Profile 3.9.2 ICON Plc Molecular Diagnostics Cancer Product Specification 3.9.3 ICON Plc Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 PlexBio 3.10.1 PlexBio Company Profile 3.10.2 PlexBio Molecular Diagnostics Cancer Product Specification 3.10.3 PlexBio Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Foundation Medicine 3.11.1 Foundation Medicine Company Profile 3.11.2 Foundation Medicine Molecular Diagnostics Cancer Product Specification 3.11.3 Foundation Medicine Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 CytoTrack 3.12.1 CytoTrack Company Profile 3.12.2 CytoTrack Molecular Diagnostics Cancer Product Specification 3.12.3 CytoTrack Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Guardant Health 3.13.1 Guardant Health Company Profile 3.13.2 Guardant Health Molecular Diagnostics Cancer Product Specification 3.13.3 Guardant Health Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Luminex 3.14.1 Luminex Company Profile 3.14.2 Luminex Molecular Diagnostics Cancer Product Specification 3.14.3 Luminex Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 10X Genomics 3.15.1 10X Genomics Company Profile 3.15.2 10X Genomics Molecular Diagnostics Cancer Product Specification 3.15.3 10X Genomics Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Merck 3.16.1 Merck Company Profile 3.16.2 Merck Molecular Diagnostics Cancer Product Specification 3.16.3 Merck Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 Biocartis 3.17.1 Biocartis Company Profile 3.17.2 Biocartis Molecular Diagnostics Cancer Product Specification 3.17.3 Biocartis Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 GenomOncology 3.18.1 GenomOncology Company Profile 3.18.2 GenomOncology Molecular Diagnostics Cancer Product Specification 3.18.3 GenomOncology Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 Biodesix 3.19.1 Biodesix Company Profile 3.19.2 Biodesix Molecular Diagnostics Cancer Product Specification 3.19.3 Biodesix Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 Bio-Techne 3.20.1 Bio-Techne Company Profile 3.20.2 Bio-Techne Molecular Diagnostics Cancer Product Specification 3.20.3 Bio-Techne Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Molecular Diagnostics Cancer Market Competition by Market Players 4.1 Global Molecular Diagnostics Cancer Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Molecular Diagnostics Cancer Revenue Market Share by Market Players (2016-2021) 4.3 Global Molecular Diagnostics Cancer Average Price by Market Players (2016-2021) 5 Global Molecular Diagnostics Cancer Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Molecular Diagnostics Cancer Market Size (2016-2021) 5.1.2 Molecular Diagnostics Cancer Key Players in North America (2016-2021) 5.1.3 North America Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.1.4 North America Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Molecular Diagnostics Cancer Market Size (2016-2021) 5.2.2 Molecular Diagnostics Cancer Key Players in East Asia (2016-2021) 5.2.3 East Asia Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.2.4 East Asia Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Molecular Diagnostics Cancer Market Size (2016-2021) 5.3.2 Molecular Diagnostics Cancer Key Players in Europe (2016-2021) 5.3.3 Europe Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.3.4 Europe Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Molecular Diagnostics Cancer Market Size (2016-2021) 5.4.2 Molecular Diagnostics Cancer Key Players in South Asia (2016-2021) 5.4.3 South Asia Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.4.4 South Asia Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Molecular Diagnostics Cancer Market Size (2016-2021) 5.5.2 Molecular Diagnostics Cancer Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.5.4 Southeast Asia Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Molecular Diagnostics Cancer Market Size (2016-2021) 5.6.2 Molecular Diagnostics Cancer Key Players in Middle East (2016-2021) 5.6.3 Middle East Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.6.4 Middle East Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Molecular Diagnostics Cancer Market Size (2016-2021) 5.7.2 Molecular Diagnostics Cancer Key Players in Africa (2016-2021) 5.7.3 Africa Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.7.4 Africa Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Molecular Diagnostics Cancer Market Size (2016-2021) 5.8.2 Molecular Diagnostics Cancer Key Players in Oceania (2016-2021) 5.8.3 Oceania Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.8.4 Oceania Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Molecular Diagnostics Cancer Market Size (2016-2021) 5.9.2 Molecular Diagnostics Cancer Key Players in South America (2016-2021) 5.9.3 South America Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.9.4 South America Molecular Diagnostics Cancer Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Molecular Diagnostics Cancer Market Size (2016-2021) 5.10.2 Molecular Diagnostics Cancer Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Molecular Diagnostics Cancer Market Size by Type (2016-2021) 5.10.4 Rest of the World Molecular Diagnostics Cancer Market Size by Application (2016-2021) 6 Global Molecular Diagnostics Cancer Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Molecular Diagnostics Cancer Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Molecular Diagnostics Cancer Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Molecular Diagnostics Cancer Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Molecular Diagnostics Cancer Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Molecular Diagnostics Cancer Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Molecular Diagnostics Cancer Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Molecular Diagnostics Cancer Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Molecular Diagnostics Cancer Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Molecular Diagnostics Cancer Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Molecular Diagnostics Cancer Consumption by Countries 7 Global Molecular Diagnostics Cancer Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Molecular Diagnostics Cancer (2022-2027) 7.2 Global Forecasted Revenue of Molecular Diagnostics Cancer (2022-2027) 7.3 Global Forecasted Price of Molecular Diagnostics Cancer (2022-2027) 7.4 Global Forecasted Production of Molecular Diagnostics Cancer by Region (2022-2027) 7.4.1 North America Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.3 Europe Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.7 Africa Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.9 South America Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Molecular Diagnostics Cancer Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Molecular Diagnostics Cancer by Application (2022-2027) 8 Global Molecular Diagnostics Cancer Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.2 East Asia Market Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.3 Europe Market Forecasted Consumption of Molecular Diagnostics Cancer by Countriy 8.4 South Asia Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.5 Southeast Asia Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.6 Middle East Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.7 Africa Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.8 Oceania Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.9 South America Forecasted Consumption of Molecular Diagnostics Cancer by Country 8.10 Rest of the world Forecasted Consumption of Molecular Diagnostics Cancer by Country 9 Global Molecular Diagnostics Cancer Sales by Type (2016-2027) 9.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2016-2021) 9.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2022-2027) 10 Global Molecular Diagnostics Cancer Consumption by Application (2016-2027) 10.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2016-2021) 10.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2022-2027) 11 Global Molecular Diagnostics Cancer Manufacturing Cost Analysis 11.1 Molecular Diagnostics Cancer Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Molecular Diagnostics Cancer 12 Global Molecular Diagnostics Cancer Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Molecular Diagnostics Cancer Distributors List 12.3 Molecular Diagnostics Cancer Customers 12.4 Molecular Diagnostics Cancer Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000